In the United States, community-acquired pneumonia is one of the leading causes of hospitalization and death, with approximately 6 million cases reported each year. 1-6 The annual incidence of ...

Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. https://www.ncbi.nlm.nih.gov ...

Community-acquired pneumonia (CAP) is a common clinical disorder with an estimated incidence range from 1.6/1,000 to 16/1,000 per year. The ...

Severe community-acquired pneumonia should be treated with a respiratory fluoroquinolone or a combination of macrolides and β-lactams. Prior exposure to a specific antimicrobial in the past 3 months ...

Community-acquired pneumonia. This is a fancy way of saying you got infected somewhere other than a hospital or long-term care facility. Community-acquired pneumonia can be caused by bacteria ...

Community-acquired pneumonia (CAP) is a prevalent and potentially serious infectious disease, characterized by the development of lung infections in individuals who have not recently been ...

Mukanhaire, L., et al. (2023) Efficacy of corticosteroids as an adjunctive therapy in the treatment of community-acquired pneumonia: a systematic review and meta-analysis. Acta Materia Medica. doi ...

Medically reviewed by Jonathan B. Jassey, DO There are more than seven main types of pneumonia, including community-acquired pneumonia caused by bacteria and viruses. Other types include walking ...

Treatment of community-acquired pneumonia typically involves either a respiratory fluoroquinolone or a combination of cephalosporin and a macrolide. Initial broad-spectrum antibiotic therapy should ...

Background The etiologic profile of community-acquired pneumonia (CAP) for each age group could be similar among inpatients and outpatients. This fact brings up the link between etiology of CAP ...